On January 7, 2025, the U.S. Food and Drug Administration (FDA) released a draft guidance titled Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations. This document consolidates and refines the agency’s existing recommendations for the content required in marketing applications for medical devices that incorporate AI-driven software functions. The goal is to […]
